The US regulator has recommended taking "a break" in the use of the vaccine against the coronavirus Johnson & Johnson after the appearance of several severe cases of blood clots across the Atlantic.

This American vaccine is authorized by the European Medicines Agency but not yet administered. 

US health officials on Tuesday recommended "a pause" in the use of Johnson & Johnson's Covid-19 vaccine to investigate the occurrence of severe cases of blood clots in several people in the United States.

>>

LIVE

- Coronavirus: follow the evolution of the situation Tuesday, April 13

The United States Medicines Agency (FDA) "is investigating six reported cases in the United States of people who developed severe cases of blood clots after receiving the vaccine" and during the investigation "we recommend a break ", she said in a statement.

>>

More information to follow ...